OncoResponse: OncoResponse receives CPRIT grant to advance OR502
OR2805 was discovered using the company's B cells discovery platform.
Read full article »
OncoResponse is a Washington-based biotechnology company that researches and develops immunotherapies for the treatment of cancer.
Read more